Cardiac abnormalities in children with malignancies at Kenyatta National Hospital

East African Medical Journal

Volumn 74, Issue 11, 1997, Pages 702-704

  Kariuki, N ^a   Macharia, W M ^a   Aseso, H O ^b  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b KENYATTA NATIONAL HOSPITAL   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOXORUBICIN;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DOSE RESPONSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PERICARDIAL EFFUSION; RADIATION INJURY; THORAX RADIOGRAPHY;

CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEART DISEASES; HOSPITALS, URBAN; HUMANS; KENYA; MALE; MORBIDITY; NEOPLASMS; PREVALENCE;

EID: 0031411150     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Kutalek S.P., Paridis I.P. and Ketler M.N. et al: Metastatic tumours of the heart detected by two-dimensional echocardiography. Amer. Heart J. 1985; 109:343.
2. Gottdiener J.S., Katin M.J. and Borer J.S. et al: Identification of subclinical cardiac abnormality 5-15 years after therapeutic mediastinal irradiation. Amer. J. Cardiol. 1980; 45:475.
3. Benjamin R.S., Wiernik P.H. and Bachur N.R.: Adriamycin chemotherapy- efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule. Cancer. 1974; 33:19-27.
4. Laurel Steinherz and Peter Steinherz: Delayed cardiac toxicity from anthracycline therapy. Pediatrics. 1991; 18:49-52.
5. Minow R.A., Benjamin R.S. and Gottheb J.A. Adriamycin (NSC-123129) cardiomyopathy: An overview with determination of risk factors. Cancer Chemother Rep. 1975; 6:195-201.
6. Lefrack E.A., Pitha J. and Rosenheim S. et al: A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973; 32:302-314.
7. Minow R.A., Benjamin R.S. and Lee E.T. Adriamycin cardiomyopathy - risk factors. Cancer. 1977; 39:1397-1402.
8. Alexander J., Dainiak N. and Berger H.J. et al: Serial assessment of Doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N. Engl J Med. 1979; 300:278.
9. Dresdale A., Bonow R. and Wesley R. et al: Prospective cardiomyopathy resulting from post surgical adjuvant treatment of patients with soft tissue sarcomas. Cancer. 1983; 52:51.
10. Steinherz L.J., Graham T. and Hurwitz R. et al: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Children's Cancer Study Group. Pediatrics. 1992; 89:942-949.
11. Branon et al: Cardiac output in patients with chronic anaemia. J Cl Investigations. 1945; 24:332.
12. Cassis N. Jr. and Porterfield J. Massive haemopericardium as the initial manifestation of chronic myelogenous leukaemia. Arch. Intern. Med. 1982; 142:2193.
13. Haskell R.J. and French W.I. Cardiac tamponade as the initial presentation of malignancy. Chest. 1985; 88:70.